About 27 million Americans suffer from arthritis, and more than three million of those cases result from a joint injury, often in the knee, that provokes slow and steady cartilage deterioration.
Sep 2, 2011
0
0
Almost one-third of new drugs approved by U.S. regulators over a decade ended up years later with warnings about unexpected, sometimes life-threatening side effects or complications, a new analysis found.
May 9, 2017
1
127
(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.
Jan 26, 2022
0
1
Millions of Americans suffer from arthritis, and many reach for medication to ease their joint pain and inflammation.
Sep 19, 2023
0
1
Although some have suggested that patients receiving medication for immune-mediated diseases such as rheumatoid arthritis or psoriasis may be at increased risk of herpes zoster (HZ; shingles) shortly after receipt of the ...
Jul 3, 2012
1
1
New research has confirmed a strong link between four genetic mutations and progressive multifocal leukoencephalopathy (PML), a rare but often fatal brain infection that can be triggered by dozens of FDA-approved drugs.
Dec 14, 2022
1
71
South Korea's government drug agency cleared the way Thursday for commercial sales of what it called the world's first approved medicine using stem cells collected from other people.
Jan 19, 2012
0
1
(HealthDay) -- About 10 percent of fibromyalgia patients use marijuana to relieve symptoms such as pain, fatigue and insomnia, a new study has found.
Jun 22, 2012
3
0
For men and women affected with antiphospholipid syndrome (APS), blood thinners are the main treatment option.
Apr 25, 2019
0
75
French pharmaceutical giant Sanofi said Friday it would offer 100 million doses of hydroxychloroquine, a treatment for rheumatoid arthritis and lupus, to governments worldwide if studies show it can safely to be used to ...
Apr 10, 2020
0
3
